Empagliflozin S-Furanose
Synchemia is a leading supplier in pharmaceutical Empagliflozin Impurities . Empagliflozin (brand name Jardiance) is a prescription medication used to manage conditions such as diabetes, heart failure, and kidney disease.
Empagliflozin S-Furanose CAS NO: 1620758-32-8 chemically represented as (2S,3R,4R,5R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol . Empagliflozin S-Furanose is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Empagliflozin S-Furanose . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39089 |
| CAS No | NA |
| Mol.F. | C23H29ClO8 |
| Mol.Wt. | 468.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39090 |
| CAS No | 874817-93-3 |
| Mol.F. | C7H4ClIO2 |
| Mol.Wt. | 282.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39091 |
| CAS No | NA |
| Mol.F. | C31H35ClO11 |
| Mol.Wt. | 619.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39092 |
| CAS No | 2262435-19-6 |
| Mol.F. | C31H35ClO12 |
| Mol.Wt. | 635.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39093 |
| CAS No | NA |
| Mol.F. | C17H17ClO3 |
| Mol.Wt. | 304.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39094 |
| CAS No | NA |
| Mol.F. | C17H17ClO3 |
| Mol.Wt. | 304.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39095 |
| CAS No | NA |
| Mol.F. | C21H23ClO4 |
| Mol.Wt. | 374.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39096 |
| CAS No | NA |
| Mol.F. | C21H23ClO4 |
| Mol.Wt. | 374.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39097 |
| CAS No | 2452301-17-4 |
| Mol.F. | C29H31ClO11 |
| Mol.Wt. | 591g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39098 |
| CAS No | 1919893-83-6 |
| Mol.F. | C13H7BrClFO |
| Mol.Wt. | 313.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39099 |
| CAS No | 1997260-73-7 |
| Mol.F. | C13H7BrClFO |
| Mol.Wt. | 313.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39100 |
| CAS No | 1157263-84-7 |
| Mol.F. | C13H7BrClFO |
| Mol.Wt. | 313.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39101 |
| CAS No | 1713015-56-5 |
| Mol.F. | C13H7Br2FO |
| Mol.Wt. | 358g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39102 |
| CAS No | 1712958-06-9 |
| Mol.F. | C13H7BrClFO |
| Mol.Wt. | 313.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39103 |
| CAS No | NA |
| Mol.F. | C19H18ClFO6 |
| Mol.Wt. | 396.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39104 |
| CAS No | NA |
| Mol.F. | C8H14O4 |
| Mol.Wt. | 174.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |